起飞加速器testflight

Early phase CRO working as a flexible, attentive extension of your team, we offer all you need to move your molecule from preclinical to Phase I, Phase II, and beyond.

Let's Get Started

play brand video

pause brand video 闪飞加速器永久免费版

We are a forward-thinking, mid-size early phase contract research organization, in Canada and the U.S., offering biopharmaceutical companies of all sizes a proven, flexible approach to early drug development, including preclinical safety testing, clinical pharmacology (Phase I to Phase II), bioanalysis (preclinical to Phase IV), research services, and manufacturing and analytical services.

Focused on your success … always available and always looking ahead. Moving in unison to deliver big impact with a personal touch.

起飞加速器testflight

We help you reach early phase drug development decision-making milestones sooner — improving speed and ease from lead candidate selection to proof of concept. Moving your program through preclinical, Phase I, Phase II, and beyond.

ALTASCIENCES Preclinical Services

Safety assessments for both small and large molecules
ALTASCIENCES Clinical Services

Clinical pharmacology trials from first-in-human to end of Phase II
ALTASCIENCES Bioanalysis & Research Services

Package or stand-alone. Preclinical, Phase I to Phase IV bioanalytical laboratories
ALTASCIENCES Manufacturing and Analytical Services

From formulation development, Phase I through commercial manufacturing, and ICH stability testing

HIGHLIGHTS

Video

Altasciences - Bioanalysis Services

Imagine - Contract Research Organization (CRO) - Altasciences

网飞加速器永久免费下载

Imagine... a Different Kind of CRO

Altasciences - Early phase contract research organization (CRO)

Resource

Altasciences' Corporate Brochure

Altasciences is a forward-thinking, mid-size, early phase contract research organization...

Video

Because Life is Everything

闪飞加速器永久免费版

Altasciences wins Most Successful Early Phase Research (Preclinical & Phase I)

Video

Altasciences Preclinical Services

Altasciences offers a full range of in vivo GLP and non-GLP preclinical evaluation studies in multiple species to thoroughly assess the safety profile of your molecules.

Video

闪飞加速器永久免费版

古域破解版下载- 全方位下载:2021-8-7 · 古域破解版古域时间：2021-08-07 大小：时间：2021-08-07 星级：立即下载古域是一款热血的魔幻题材传奇类手游。热血对战竞技内容体验，续写沙城传奇故事，称王败寇，胜利者才能享受最后的荣耀。新的英雄结伴战 ...

飞兔加速器安卓版

Altasciences appointed by Indivior to conduct Phase I clinical trial with C4XD’s Orexin-1 for treatment of Opioid Use Disorder

Category News

Altasciences appointed by Indivior to conduct Phase I clinical trial with C4XD’s Orexin-1 for treatment of Opioid Use Disorder

READ MORE
Category

Chris Perkin - Transforming the Industry With a People-Focused Approach by PharmaVoice Red Jacket Awards
Category

Top 10 Drug Discovery & Preclinical CROs to watch as we inch closer to Q4 and 2020, Brandon Miller

OPPORTUNITY 黑洞加速器破解版app GROWTH WORK LIFE

飞翔加速器破解版

No important medicine is developed by one person. Early phase drug development takes teams of dedicated individuals, working in synergy, to create something that transforms lives. Together, we work hard, have fun, and innovate continuously, getting medicines to the people who need them, faster.

Testimonials

…an important partner in our development efforts and we recommend them for any ligand-binding requirements.

Bryan Tayefeh, Assistant Director, Alliance Management Ionis Pharmaceuticals, Inc.

迅游手游加速器VIP破解版v5.1.19.0_软件仓库_QQ风云网 ...:2021-2-28 · 点点特效V1.3.0高级破解版巧影专业视频剪辑器破解版v4.12.3 新海阔视界v1.20清爽版 vip影视免费看迅游手游加速器VIP破解版v5.1.19.0 安卓酷我音乐会员破解版V9.2.9.4 安卓云闪付v7.0.5谷歌版讯飞输入法v9.1.9谷歌清爽版轻阅读v1.0去广告破解版

R. Brent Miller, Ph.D., PMP Vice President, Product & Portfolio Development NeuroTrauma Sciences, LLC

It was easy to work with them and they were always willing to take the time to discuss any concerns and respond to questions.

Marie-Françoise Temam, Associate Director, Clinical Operations, Idenix, a wholly-owned subsidiary of Merck & Company

I recommend this site because of the expertise and quality of trials performed.

Okba Haj-Ali Saflo, Clinical Research Scientist, Chemo Group

...the communication between our teams was optimal, from the first protocol draft to the delivery of final report.

Maxime Ranger, President and CEO, gIcare pharma inc

We have been very pleased with their record of timely recruitment, including ensuring an inventory of back-up study participants.

Hélène Dulude, B.Pharm., Ph.D., Director, Clinical Development, Locemia Solutions ULC

起飞加速器testflight

起飞加速器testflight

ALTASCIENCES Preclinical Services

ALTASCIENCES Clinical Services

ALTASCIENCES Bioanalysis & Research Services

ALTASCIENCES Manufacturing and Analytical Services